地中海饮食模式对社区老年人的认知状态的影响
Nathalie Yaghi1, Rita El Hayeck2, Christa Boulos1
1Department of Nutrition & Dietetics, Faculty of Pharmacy, Saint Joseph University, Beirut 1107 2180, Lebanon.
Nutrients
|September 28, 2023
概括
老年黎巴嫩成年人的认知能力下降 (CD) 与饮食模式 (DPs) 有关,但仅适用于识字的人. 文盲改变了与CD相关的因素,不包括饮食和虚弱.
科学领域:
- 老年学是一门学科.
- 营养科学 营养科学
- 公共卫生 公共卫生
背景情况:
- 可修改的因素,特别是饮食模式 (DPs),对于了解老年人群认知衰退 (CD) 至关重要.
- 关于中东地区经济地位较低的老年人中CD和DP的研究有限.
- 识字可能会影响生活方式因素与认知健康之间的关系.
研究的目的:
- 调查认知衰退与相关因素,特别是饮食模式之间的联系,在社区居住的黎巴嫩老年人中.
- 探索识字在饮食模式和认知衰退之间的关系中的作用.
- 为了确定可修改的认知衰退的风险因素,在一个脆弱的老年人群.
主要方法:
- 在352名60岁以上的黎巴嫩成年人中进行了全国横截面研究.
- 基于识字状态的认知衰退查.
- 使用K-平均集群分析对经过验证的食物频率调查问卷数据确定的饮食模式.
主要成果:
- 在文盲 (61.5%) 与识字 (32.7%) 参与者中,认知能力下降显著高于文盲 (61.5%).
- 在识字的人群中,CD与年龄 (>80岁) 相关,生活在贝鲁特,脆弱,以及西方化或高摄入地中海DP.
- 在文盲个体中,CD与年龄 (>78) 和居住在贝鲁特有关,但与DPS或虚弱无关.
结论:
- 与黎巴嫩老年人认知能力下降相关的因素依赖于识字能力.
- 饮食模式仅在识字的老年人群中是认知能力下降的重要风险因素.
- 针对认知衰退的干预措施应考虑识字水平和特定的饮食模式.
更多相关视频
06:58Highlighting and Reducing the Impact of Negative Aging Stereotypes During Older Adults' Cognitive Testing
Published on: January 24, 2020
7.4K
07:01Working Memory Training for Older Participants: A Control Group Training Regimen and Initial Intellectual Functioning Assessment
Published on: September 20, 2020
4.8K
相关概念视频
01:30Cognitive Development During Adulthood
142
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
142
01:30Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
147
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
147
01:26Alzheimer's Disease: Overview
513
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
513
01:22Alzheimer's Disease: Treatment
212
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
212
01:26Atherosclerosis III: Management
11
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
11
01:30Dementia
131
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
131